Clinical Trial

Dietary Interventions to Reduce Ultra-Processed Food Intake

Study acronym: DISRUPT
Not Yet Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The DISRUPT clinical trial will test two different 2-month programs to help adults with overweight/obesity (N=60) reduce their intake of ultra-processed foods (UPFs). Participants will be randomly assigned to receive standard dietary change strategies, cognitive dissonance strategies that engage them in activism against the UPF industry, or both. All participants will attend an introductory educational workshop about UPFs. If they are assigned to receive one or more of these strategies, they will attend weekly group sessions with the relevant intervention content for 7 more weeks. Groups will be held virtually.
Trial Details
NCT Number NCT07226336
Lead Sponsor Oregon Research Institute
Collaborators: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Albert Einstein College of Medicine
Conditions Ultra-Processed Food Intake, Obesity & Overweight
Enrollment 60 participants
Start Date 2026-02
Primary Completion 2026-08 (estimated)
Study Completion 2026-08 (estimated)
Updated on ClinicalTrials.gov 2025-11-10